Life Sciences
Healthcare, Biotech & Pharmaceuticals
Novartis is focused on five core therapeutic areas with high unmet patient needs and five technology platforms that enable cutting-edge innovative therapies, the industry leader is consistently ranked in the global top five and is one of the world's largest biopharma companies.
With $45bn+ in annual revenue and a $200bn+ market cap, Novartis has been steadily expanding its pipeline through strategic bolt-on acquisitions and continues to focus as a pure-play innovative medicines company to impact the lives of 250m+ patients and their loved ones every year.
Life Sciences
Healthcare, Biotech & Pharmaceuticals
Accenture is the largest global professional services firm, helping drive change through incredible talent and innovative technology. Accenture helps companies grow with a unique blend of strategy, consulting, technology, operations and the biggest creative agency group in the world.
With $65bn+ in annual revenue and a $250bn+ market cap, Accenture is uniquely equipped to help healthcare clients rethink, reshape and restructure their business to deliver better patient outcomes by accelerating innovation, driving transformation and leveraging data to scale AI.
Life Sciences
Healthcare & Pharmaceuticals
Founded in 1781, Takeda is Japan's oldest pharmaceutical company and one of the country's most prestigious healthcare brands. Takeda acquired Millennium Pharmaceuticals to give it product depth and Nycomed to gain geographic breadth, it has since grown even further.
In 2019, Takeda acquired Shire and secured it's position as a Top 15 biopharmaceutical company globally with $30bn+ in annual revenue and a $45bn+ market cap, the company has also invested heavily in AI since 2020 through its partnership with the Massachusetts Institute of Technology.
Life Sciences
Agribusiness & Farming
Formed as a merger between Novartis and AstraZeneca, Syngenta is a world leader in agricultural science and innovation helping to improve global food security by enabling millions of farmers to make better use of available resources through its technology solutions and services.
Following the failed buyout by Monsanto in 2015, ChemChina announced it would acquire Syngenta in 2016 for $43bn in the biggest acquisition ever made by a Chinese company. In 2020, ChemChina transferred its agribusiness assets to prepare for the largest listing in China's history.
Others
Media & Technology and PE-backed SMEs
The Economist Group is the leading source of analysis on international business and world affairs, delivering information through a range of formats to executives and leaders worldwide.
Host Europe Group, now part of GoDaddy, a market leader for cloud services, building powerful online identities for 16 million customers across 125 countries with 70+ million domain names.
Driving growth and delivering operational efficiency on the frontline of multiple PE-backed SMEs in the portfolios of CVC, Bridgepoint, TDR and Oakley with annual revenues of <$100m to $1bn+.
.png){kind=small}
.png){kind=small}
